Combination of gemcitabine and cisplatin for biliary tract cancer: A platform to build on

被引：22

作者：

Razumilava, Nataliya ^{[1
]}

Gores, Gregory J. ^{[1
]}

机构：

[1] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA

来源：

JOURNAL OF HEPATOLOGY | 2011年 / 54卷 / 03期

关键词：

PHASE-II;

D O I：

10.1016/j.jhep.2010.10.010

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：577 / 578

页数：2

共 50 条

[31] SYNERGISTIC EFFECTES OF GEMCITABINE AND CISPLATIN IN 17 BILIARY TRACT CANCER CELL LINES
Sakamoto, Yasunari
Yamagishi, Seri
Okusaka, Takuji
Ojima, Hidenori
GASTROENTEROLOGY, 2018, 154 (06) : S954 - S954
[32] Gemcitabine plus oxaliplatin combination in patients with advanced biliary tract cancer
Vattemi, E.
Lusso, M.
Pedersini, R.
Baier, S.
Cretella, E.
Petric, M.
Stocker, J.
Graiff, C.
ANNALS OF ONCOLOGY, 2007, 18 : VII111 - VII111
[33] Population pharmacokinetics and exposure-response analysis of durvalumab in combination with gemcitabine and cisplatin in patients with advanced biliary tract cancer
Aburough Abegesah
Do-Youn Oh
KyoungSoo Lim
Chunling Fan
Cecil Chen
Chong Kim
Julie Wang
Ioannis Xynos
Magdalena Zotkiewicz
Song Ren
Alex Phipps
Megan Gibbs
Diansong Zhou
Cancer Chemotherapy and Pharmacology, 2025, 95 (1)
[34] Clinical trials of gemcitabine/cisplatin/S-1 (GCS) combination therapy for patients with advance biliary tract cancer
Kanai, Masashi
Hatano, Etsuro
Nagano, Hiroaki
Ioka, Tatsuya
ANNALS OF ONCOLOGY, 2016, 27
[35] Cost-effectiveness of gemcitabine + cisplatin vs. gemcitabine monotherapy in advanced biliary tract cancer
Roth J.A.
Carlson J.J.
Journal of Gastrointestinal Cancer, 2012, 43 (2) : 215 - 223
[36] A randomized study of gemcitabine/cisplatin versus single-agent gemcitabine in patients with biliary tract cancer
Furuse, J.
Okusaka, T.
Miyazaki, M.
Taniai, H.
Nimura, Y.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[37] Phase I trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer
Watanabe, Akinori
Kida, Mitsuhiro
Miyazawa, Shiro
Iwai, Tomohisa
Okuwaki, Kosuke
Kaneko, Toru
Yamauchi, Hiroshi
Takezawa, Miyoko
Imaizumi, Hiroshi
Koizumi, Wasaburo
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (19) : 5979 - 5984
[38] A Retrospective Study of Chemotherapy with Cisplatin Plus Gemcitabine After the Failure of Gemcitabine Monotherapy for Biliary Tract Cancer
Kameda, Ryo
Ando, Tomoko
Kobayashi, Satoshi
Ueno, Makoto
Ohkawa, Shinichi
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (06) : 636 - 640
[39] Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer (vol 362, pg 1273, 2010)
Valle, Juan
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (02): : 198 - 198
[40] Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study
Rimini, Margherita
Masi, Gianluca
Lonardi, Sara
Pressiani, Tiziana
Lavacchi, Daniele
Nichetti, Federico
Jessica, Lucchetti
Giordano, Guido
Scartozzi, Mario
Tamburini, Emiliano
Pastorino, Alessandro
Rapposelli, Ilario Giovanni
Daniele, Bruno
Martinelli, Erika
Garajova, Ingrid
Aprile, Giuseppe
Schirripa, Marta
Formica, Vincenzo
Salani, Francesca
Winchler, Costanza
Bergamo, Francesca
Balsano, Rita
Gusmaroli, Eleonora
Lorenzo, Angotti
Landriscina, Matteo
Pretta, Andrea
Toma, Ilaria
Pirrone, Chiara
Diana, Anna
Leone, Francesco
Brunetti, Oronzo
Brandi, Giovanni
Garattini, Silvio Ken
Satolli, Maria Antonietta
Rossari, Federico
Fornaro, Lorenzo
Niger, Monica
Zanuso, Valentina
De Rosa, Antonio
Ratti, Francesca
Aldrighetti, Luca
De Braud, Filippo
Foti, Silvia
Rizzato, Mario Domenico
Vivaldi, Caterina
Stefano, Cascinu
Rimassa, Lorenza
Antonuzzo, Lorenzo
Casadei-Gardini, Andrea
TARGETED ONCOLOGY, 2024, 19 (3) : 359 - 370

← 1 2 3 4 5 →